Zelip 5 Tablet contains Clobazam 5 mg, a benzodiazepine derivative primarily indicated for the management of epilepsy and anxiety disorders. Clobazam exerts its therapeutic effects by enhancing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system, thereby producing anticonvulsant and anxiolytic effects. Zelip 5 is commonly prescribed as an adjunctive treatment for various seizure types, including Lennox-Gastaut syndrome, as well as for short-term relief of anxiety symptoms. The tablet should be administered orally, with dosage individualized based on the patient’s clinical condition, response to therapy, and tolerability. Common adverse effects may include drowsiness, dizziness, fatigue, and ataxia, with caution advised in patients with a history of substance abuse or respiratory insufficiency. Abrupt discontinuation should be avoided to prevent withdrawal symptoms or seizure exacerbation; gradual dose tapering is recommended. Zelip 5 is contraindicated in patients with hypersensitivity to Clobazam or other benzodiazepines, and it should be used cautiously in the elderly and those with hepatic or renal impairment. Regular monitoring and adherence to prescribed dosing are essential to optimize therapeutic outcomes and minimize risks associated with long-term benzodiazepine use.